X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Wockhardt - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. WOCKHARDT LTD. FDC LTD./
WOCKHARDT LTD.
 
P/E (TTM) x 17.2 16.3 105.6% View Chart
P/BV x 3.6 1.7 215.8% View Chart
Dividend Yield % 1.3 0.0 -  

Financials

 FDC LTD.   WOCKHARDT LTD.
EQUITY SHARE DATA
    FDC LTD.
Mar-14
WOCKHARDT LTD.
Mar-16
FDC LTD./
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1442,000 7.2%   
Low Rs79706 11.2%   
Sales per share (Unadj.) Rs47.6403.7 11.8%  
Earnings per share (Unadj.) Rs7.629.5 25.8%  
Cash flow per share (Unadj.) Rs9.042.4 21.3%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5323.4 14.7%  
Shares outstanding (eoy) m177.83110.51 160.9%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.4 69.8%   
Avg P/E ratio x14.645.9 31.8%  
P/CF ratio (eoy) x12.331.9 38.7%  
Price / Book Value ratio x2.34.2 55.9%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,784149,509 13.2%   
No. of employees `000NA7.4 0.0%   
Total wages/salary Rs m1,2219,443 12.9%   
Avg. sales/employee Rs ThNM6,048.6-  
Avg. wages/employee Rs ThNM1,280.2-  
Avg. net profit/employee Rs ThNM441.5-  
INCOME DATA
Net Sales Rs m8,45944,614 19.0%  
Other income Rs m394970 40.6%   
Total revenues Rs m8,85245,584 19.4%   
Gross profit Rs m2,0705,038 41.1%  
Depreciation Rs m2491,426 17.5%   
Interest Rs m311,012 3.1%   
Profit before tax Rs m2,1843,570 61.2%   
Minority Interest Rs m0-65 0.0%   
Prior Period Items Rs m-2256 -3,514.1%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m606255 237.7%   
Profit after tax Rs m1,3533,257 41.6%  
Gross profit margin %24.511.3 216.7%  
Effective tax rate %27.77.1 388.6%   
Net profit margin %16.07.3 219.2%  
BALANCE SHEET DATA
Current assets Rs m4,35539,906 10.9%   
Current liabilities Rs m1,79218,423 9.7%   
Net working cap to sales %30.348.2 62.9%  
Current ratio x2.42.2 112.2%  
Inventory Days Days4490 49.3%  
Debtors Days Days2598 25.1%  
Net fixed assets Rs m3,02535,832 8.4%   
Share capital Rs m179553 32.3%   
"Free" reserves Rs m8,24330,370 27.1%   
Net worth Rs m8,45335,739 23.7%   
Long term debt Rs m1116,542 0.1%   
Total assets Rs m10,55779,522 13.3%  
Interest coverage x71.44.5 1,577.4%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x0.80.6 142.8%   
Return on assets %13.15.4 244.3%  
Return on equity %16.09.1 175.7%  
Return on capital %23.58.7 271.7%  
Exports to sales %13.311.6 114.7%   
Imports to sales %3.34.5 75.0%   
Exports (fob) Rs m1,1265,177 21.7%   
Imports (cif) Rs m2831,990 14.2%   
Fx inflow Rs m1,1467,589 15.1%   
Fx outflow Rs m3552,878 12.3%   
Net fx Rs m7914,711 16.8%   
CASH FLOW
From Operations Rs m1,485716 207.4%  
From Investments Rs m-620-8,182 7.6%  
From Financial Activity Rs m-7532,543 -29.6%  
Net Cashflow Rs m113-4,923 -2.3%  

Share Holding

Indian Promoters % 68.9 74.5 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 2.3 204.3%  
FIIs % 7.5 7.7 97.4%  
ADR/GDR % 0.0 0.1 -  
Free float % 19.0 15.4 123.4%  
Shareholders   23,730 67,757 35.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   DR. REDDYS LAB  IPCA LABS  JUBILANT LIFE SCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Aug 21, 2017 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - TORRENT PHARMA COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS